A Spheroid Killing Assay by CAR T Cells

Immunotherapy has become a field of growing interest in the fight against cancer otherwise untreatable. Among all immunotherapeutic methods, chimeric ...

Oslo University Hospital-Radiumhospitalet

Although chemo-immunotherapy has led to an improved overall survival for most B-cell lymphoma types, relapsed and refractory disease remains a challenge. The malaria drug artesunate has previously been identified as a growth suppressor in some cancer types and was tested as a new treatment option in B-cell lymphoma.

Pierre Dillard

Department of Cellular Therapy,
Department of Oncology,
Department of Cellular Therapy, Department of Oncology

Oslo University Hospital-Radiumhospitalet

A Spheroid Killing Assay by CAR T Cells

Pierre Dillard

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Cellular Therapy,Department of Oncology,Department of Cellular Therapy, Department of Oncology

Oslo University Hospital-Radiumhospitalet

A Spheroid Killing Assay by CAR T Cells

Department of Cellular Therapy,
Department of Oncology,
Department of Cellular Therapy, Department of Oncology